Articles with public access mandates - Marwan FakihLearn more
Available somewhere: 65
p53MVA Therapy in Patients with Refractory Gastrointestinal Malignancies Elevates p53-Specific CD8+ T-cell Responses
NR Hardwick, M Carroll, T Kaltcheva, D Qian, D Lim, L Leong, P Chu, ...
Clinical Cancer Research 20 (17), 4459-4470, 2014
Mandates: US National Institutes of Health
Methyl selenocysteine: single-dose pharmacokinetics in men
JR Marshall, C Ip, K Romano, G Fetterly, M Fakih, B Jovanovic, M Perloff, ...
Cancer Prevention Research 4 (11), 1938-1944, 2011
Mandates: US National Institutes of Health
Adenoviral-based vaccine promotes neoantigen-specific CD8+ T cell stemness and tumor rejection
AM D’Alise, N Brasu, C De Intinis, G Leoni, V Russo, F Langone, D Baev, ...
Science translational medicine 14 (657), eabo7604, 2022
Mandates: US National Institutes of Health, AIRC Foundation for Cancer Research in Italy
Therapeutic targeting of SLC6A8 creatine transporter suppresses colon cancer progression and modulates human creatine levels
I Kurth, N Yamaguchi, C Andreu-Agullo, HS Tian, S Sridhar, S Takeda, ...
Science advances 7 (41), eabi7511, 2021
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Epidermal growth factor receptor signaling to the mitogen activated protein kinase pathway bypasses Ras in pancreatic cancer cells
S Lee, EL Heinrich, J Lu, W Lee, AH Choi, C Luu, V Chung, M Fakih, ...
Pancreas 45 (2), 286-292, 2016
Mandates: US National Institutes of Health
A Pilot Feasibility Study of Yttrium‐90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases
C Wang, J Park, C Ouyang, JA Longmate, M Tajon, J Chao, D Lim, ...
The Oncologist 25 (5), 382-e776, 2020
Mandates: US National Institutes of Health
Regorafenib, ipilimumab, and nivolumab for patients with microsatellite stable colorectal cancer and disease progression with prior chemotherapy: a phase 1 nonrandomized …
M Fakih, J Sandhu, D Lim, X Li, S Li, C Wang
JAMA oncology 9 (5), 627-634, 2023
Mandates: US National Institutes of Health
Pilot trial of CRLX101 in patients with advanced, chemotherapy-refractory gastroesophageal cancer
J Chao, J Lin, P Frankel, AJ Clark, DT Wiley, E Garmey, M Fakih, D Lim, ...
Journal of Gastrointestinal Oncology 8 (6), 962, 2017
Mandates: US National Institutes of Health
A phase II study of axalimogene filolisbac for patients with previously treated, unresectable, persistent/recurrent loco-regional or metastatic anal cancer
C Eng, M Fakih, M Amin, V Morris, HS Hochster, PM Boland, H Uronis
Oncotarget 11 (15), 1334, 2020
Mandates: US National Institutes of Health
Rationale, development, and design of the Altering Intake, Managing Symptoms (AIMS) dietary intervention for bowel dysfunction in rectal cancer survivors
V Sun, TE Crane, SD Slack, A Yung, S Wright, S Sentovich, K Melstrom, ...
Contemporary clinical trials 68, 61-66, 2018
Mandates: US National Institutes of Health
Pilot study of an interdisciplinary supportive care planning intervention in pancreatic cancer
V Sun, N Ruel, V Chung, G Singh, L Leong, M Fakih, Y Fong, B Ferrell
Supportive Care in Cancer 24, 3417-3424, 2016
Mandates: US National Institutes of Health
Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis
M Aftabizadeh, YJ Li, Q Zhao, C Zhang, N Ambaye, J Song, T Nagao, ...
JCI insight 6 (2), 2021
Mandates: US National Institutes of Health
Safety and effectiveness of aflibercept+ fluorouracil, leucovorin, and irinotecan (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) in current …
I Chau, M Fakih, P García-Alfonso, Z Linke, A Ruiz Casado, EP Marques, ...
Cancers 12 (3), 657, 2020
Mandates: National Institute for Health Research, UK
MEK162 enhances antitumor activity of 5-fluorouracil and trifluridine in KRAS-mutated human colorectal cancer cell lines
J Gong, Y Chen, L Yang, R Pillai, S Shirasawa, M Fakih
Anticancer research 37 (6), 2831-2838, 2017
Mandates: US National Institutes of Health
SUMOylation of E2F1 regulates expression of EZH2
L Du, MG Fakih, ST Rosen, Y Chen
Cancer research 80 (19), 4212-4223, 2020
Mandates: US National Institutes of Health, State of Califonia
A phase I clinical trial of binimetinib in combination with FOLFOX in patients with advanced metastatic colorectal cancer who failed prior standard therapy
M Cho, J Gong, P Frankel, TW Synold, D Lim, V Chung, J Chao, D Li, ...
Oncotarget 8 (45), 79750, 2017
Mandates: US National Institutes of Health
Acquired resistance to KRAS G12C small-molecule inhibitors via genetic/nongenetic mechanisms in lung cancer
A Mohanty, A Nam, S Srivastava, J Jones, B Lomenick, SS Singhal, L Guo, ...
Science Advances 9 (41), eade3816, 2023
Mandates: Department of Biotechnology, India, Department of Science & Technology, India
Recall of genomic testing results among patients with cancer
SE Wing, H Hu, L Lopez, I Solomon, J Shen, C Raquel, M Sur, J Chao, ...
The Oncologist 26 (12), e2302-e2305, 2021
Mandates: US National Institutes of Health
Rationale and design of a telehealth self-management, shared care intervention for post-treatment survivors of lung and colorectal cancer
V Sun, A Reb, M Debay, M Fakih, B Ferrell
Journal of Cancer Education 36, 414-420, 2021
Mandates: US National Institutes of Health
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer
C Li, A Ferro, SK Mhatre, D Lu, M Lawrance, X Li, S Li, S Allen, J Desai, ...
Communications Medicine 2 (1), 90, 2022
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program